Lexington Biosciences Inc.
Lexington Biosciences, Inc. is a development stage medical device company operating within the healthcare industry. Lexington is focused on development and commercialization of non-invasive cardiovascular health monitoring products to allow predictive diagnosis of future cardiovascular events. The current focus of the company is to develop and market the HeartSentry endothelial function measurement product.
Lexington Biosciences Inc. (LNB)
le 1 mai/May 2020
At the request of the company the common shares of Lexington Biosciences Inc. will be delisted at market close on May 4, 2020.
For further information please see the issuer’s press release.
À la demande de la société, les actions ordinaires de Lexington Biosciences Inc. seront radiées de la cote à la fermeture des marchés le 4 mai 2020.